An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.
Clinical trial NCT01108887 · COMPLETED
Trial details
- NCT number
- NCT01108887
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.